2 Year Absolute Returns
52.16% ↑
NAV (₹) on 19 Jun 2026
19.96
1 Day NAV Change
0.99%
Risk Level
Very High Risk
Rating
-
HDFC Pharma and Healthcare Fund is a Equity mutual fund categorized under Sector, offered by HDFC Asset Management Company Ltd.. Launched on 14 Sep 2023, investors can start with a minimum SIP of ₹100 ... Read more
AUM
₹ 2,362.44 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 71.18% |
| Hospitals & Medical Services | 26.87% |
| Treps/Reverse Repo | 1.49% |
| Medical Equipment & Accessories | 0.63% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 9.20% | ₹ 217.44 | Pharmaceuticals |
| Divis Laboratories Ltd. | 8.02% | ₹ 189.40 | Pharmaceuticals |
| Lupin Ltd. | 5.45% | ₹ 128.87 | Pharmaceuticals |
| Max Healthcare Institute Limited | 5.26% | ₹ 124.37 | Hospitals & Medical Services |
| Aster DM Healthcare Limited | 5.18% | ₹ 122.44 | Hospitals & Medical Services |
| Cipla Ltd. | 4.92% | ₹ 116.29 | Pharmaceuticals |
| Acutaas Chemicals Limited | 4.50% | ₹ 106.19 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 4.36% | ₹ 103.08 | Pharmaceuticals |
| Anthem Biosciences Limited | 4.15% | ₹ 98.16 | Pharmaceuticals |
| Ipca Laboratories Ltd. | 3.50% | ₹ 82.58 | Pharmaceuticals |
| Fortis Healthcare Limited | 3.41% | ₹ 80.49 | Hospitals & Medical Services |
| Glenmark Pharmaceuticals Ltd. | 3.28% | ₹ 77.55 | Pharmaceuticals |
| Laurus Labs Ltd. | 3.17% | ₹ 74.82 | Pharmaceuticals |
| Krishna Institute Of Medical Sciences Limited | 3.16% | ₹ 74.72 | Hospitals & Medical Services |
| Global Health Limited | 3.08% | ₹ 72.76 | Hospitals & Medical Services |
| Neuland Laboratories Limited | 2.98% | ₹ 70.43 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 2.70% | ₹ 63.87 | Hospitals & Medical Services |
| Metropolis Healthcare Ltd. | 2.54% | ₹ 60.06 | Hospitals & Medical Services |
| Zydus Lifesciences Limited | 2.50% | ₹ 59.15 | Pharmaceuticals |
| Wockhardt Ltd. | 2.44% | ₹ 57.55 | Pharmaceuticals |
| Shilpa Medicare Ltd | 2.28% | ₹ 53.92 | Pharmaceuticals |
| Sai Life Sciences Limited | 1.78% | ₹ 41.99 | Pharmaceuticals |
| Eris Lifesciences Ltd | 1.61% | ₹ 37.96 | Pharmaceuticals |
| Thyrocare Technologies Ltd. | 1.54% | ₹ 36.41 | Hospitals & Medical Services |
| TREPS - Tri-party Repo | 1.49% | ₹ 35.12 | Others |
| Rubicon Research Limited | 1.35% | ₹ 31.90 | Pharmaceuticals |
| Jubilant Pharmova Limited | 1.34% | ₹ 31.60 | Pharmaceuticals |
| Biocon Ltd. | 1.33% | ₹ 31.43 | Pharmaceuticals |
| Gland Pharma Ltd. | 1.19% | ₹ 28.17 | Pharmaceuticals |
| BAJAJ HEALTHCARE LIMITED | 0.73% | ₹ 17.19 | Pharmaceuticals |
| Novartis India Ltd. | 0.64% | ₹ 15.10 | Pharmaceuticals |
| Laxmi Dental Limited | 0.63% | ₹ 14.99 | Medical Equipment & Accessories |
| Cohance Lifesciences Limited | 0.46% | ₹ 10.79 | Pharmaceuticals |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 13.08% | 22.80% | 23.35% | - |
| Category returns | 1.21% | 5.68% | 6.27% | 22.53% |
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.45 | 17.51% | 191.18% | 0.00% | ₹9,724 | 1.75% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
HDFC Silver ETF
ETF
Regular
|
₹220.04 | 111.66% | 208.25% | 0.00% | ₹8,257 | 0.50% |
Very High
|
|
HDFC Silver ETF Fund of Fund - Direct Plan
Fund of Funds
Direct
|
₹38.23 | 110.72% | 206.28% | 0.00% | ₹4,894 | 0.21% |
Very High
|
|
HDFC Silver ETF Fund of Fund
Fund of Funds
Regular
|
₹37.71 | 109.90% | 203.06% | 0.00% | ₹4,894 | 0.55% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.45 | 17.51% | 191.18% | 0.00% | ₹9,724 | 1.75% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.45 | 17.51% | 191.18% | 0.00% | ₹9,724 | 1.75% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.45 | 17.51% | 191.18% | 0.00% | ₹9,724 | 1.75% |
Very High
|
|
HDFC Gold ETF Fund of Fund - Direct Plan
Fund of Funds
Direct
|
₹45.19 | 44.75% | 137.52% | 191.98% | ₹12,121 | 0.20% |
High
|
What is the current NAV of HDFC Pharma and Healthcare Fund Regular IDCW?
What is the fund size (AUM) of HDFC Pharma and Healthcare Fund Regular IDCW?
What are the historical returns of HDFC Pharma and Healthcare Fund Regular IDCW?
What is the risk level of HDFC Pharma and Healthcare Fund Regular IDCW?
What is the minimum investment amount for HDFC Pharma and Healthcare Fund Regular IDCW?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article